Summary: Psych Congress committee members discuss current psychedelic research, focusing on MDMA-assisted psychotherapy for PTSD, and psilocybin-assisted therapy for anxiety associated with life-threatening illnesses. “MDMA has been looked at as an adjunct to psychotherapy, has been found to have incredible outcomes,” explains Andrew Penn, RN.
Originally appearing here.
Psych Congress Steering Committee members Andrew Penn, RN, MS, NP, CNS, APRN-BC, and Saundra Jain, MA, PsyD, LPC, discuss the latest research on the use of psychedelics with psychotherapy.
